Skip to content
Home/Companies/Biotech/Atrandi Biosciences
Atrandi Biosciences

Atrandi Biosciences

Biotech·Lithuania·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Atrandi Biosciences?

Atrandi Biosciences is currently owned by Vsquared Ventures through Vsquared Ventures II (2024 vintage), since 2025.

Hand-verified · updated 2026-07-07

Vsquared Ventures
Investor
Vsquared Ventures
Vsquared Ventures II · 2024 · VC

Key facts

HQLithuania
SectorBiotech
StatusActive
Websiteatrandi.com

More from Vsquared Ventures II

Other portfolio companies in the same fund.

Arlequin AI
Active
SoftwareFrance· 2025
Belfort
Belfort
Active
Deep TechBelgium· 2025
Hedera Dx
Hedera Dx
Active
HealthcareSwitzerland· 2025
Pulsetrain
Active
EnergyGermany· 2025
Cylib
Cylib
Active
ClimateTechGermany· 2024
Kano Therapeutics
Kano Therapeutics
Active
BiotechUS· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
Elkedonia
Elkedonia
Active
Capital Grand EstFrance
Track Atrandi Biosciences

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Atrandi Biosciences?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Atrandi Biosciences.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue